Virax Biolabs Group Statistics

Total Valuation

VRAX has a market cap or net worth of $2.79 million. The enterprise value is -$2.14 million.

Market Cap	2.79M
Enterprise Value	-2.14M

Important Dates

The next estimated earnings date is Tuesday, June 11, 2024, before market open.

Earnings Date	Jun 11, 2024
Ex-Dividend Date	n/a

Share Statistics

VRAX has 2.36 million shares outstanding. The number of shares has increased by 664.03% in one year.

Shares Outstanding	2.36M
Shares Change (YoY)	+664.03%
Shares Change (QoQ)	+67.01%
Owned by Insiders (%)	26.80%
Owned by Institutions (%)	0.76%
Float	1.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	35.15
Forward PS	n/a
PB Ratio	0.44
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.59, with a Debt / Equity ratio of 0.03.

Current Ratio	7.59
Quick Ratio	n/a
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-432.43

Financial Efficiency

Return on equity (ROE) is -129.10% and return on invested capital (ROIC) is -107.42%.

Return on Equity (ROE)	-129.10%
Return on Assets (ROA)	-112.40%
Return on Capital (ROIC)	-107.42%
Revenue Per Employee	$7,209
Profits Per Employee	-$629,412
Employee Count	11
Asset Turnover	0.01
Inventory Turnover	3.08

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -69.87% in the last 52 weeks.

Beta (1Y)	n/a
52-Week Price Change	-69.87%
50-Day Moving Average	0.76
200-Day Moving Average	1.76
Relative Strength Index (RSI)	77.85
Average Volume (30 Days)	45,520

Short Selling Information

The latest short interest is 600, so 0.03% of the outstanding shares have been sold short.

Short Interest	600
Short Previous Month	701
Short % of Shares Out	0.03%
Short % of Float	0.05%
Short Ratio (days to cover)	0.02

Income Statement

In the last 12 months, VRAX had revenue of $79,301 and -$6.92 million in losses. Loss per share was -$2.94.

Revenue	79,301
Gross Profit	9,035
Operating Income	-7.00M
Pretax Income	-6.92M
Net Income	-6.92M
EBITDA	n/a
EBIT	-6.91M
Loss Per Share	-$2.94

Full Income Statement

Balance Sheet

The company has $5.11 million in cash and $181,706 in debt, giving a net cash position of $4.93 million or $2.09 per share.

Cash & Cash Equivalents	5.11M
Total Debt	181,706
Net Cash	4.93M
Net Cash Per Share	$2.09
Equity / Book Value	6.33M
Book Value Per Share	2.68
Working Capital	5.18M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$5.34 million and capital expenditures -$708,181, giving a free cash flow of -$6.05 million.

Operating Cash Flow	-5.34M
Capital Expenditures	-708,181
Free Cash Flow	-6.05M
FCF Per Share	-$3.41

Full Cash Flow Statement

Margins

Gross margin is 11.39%, with operating and profit margins of -8,825.12% and -8,730.70%.

Gross Margin	11.39%
Operating Margin	-8,825.12%
Pretax Margin	-8,730.70%
Profit Margin	-8,730.70%
EBITDA Margin	n/a
EBIT Margin	-8,710.56%
FCF Margin	-7,628.04%

Dividends & Yields

VRAX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-664.03%
Shareholder Yield	-664.03%
Earnings Yield	-248.42%
FCF Yield	-217.04%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on December 18, 2023. It was a reverse split with a ratio of 1:10.

Last Split Date	Dec 18, 2023
Split Type	Reverse
Split Ratio	1:10

Scores

VRAX has an Altman Z-Score of -3.48 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.48
Piotroski F-Score	3